ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer

Tekijä Moecks, Joachim, Soulières, Denis, Klughammer, Barbara
Julkaisussa J Pathol Clin Res (2015)

Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-...

Tekijä Paz-Ares, Luis, Moecks, Joachim, Klughammer, Barbara
Julkaistu 2011

Fast Induction of High-Affinity HCO(3)(−) Transport in Cyanobacteria

Tekijä Sültemeyer, Dieter, Klughammer, Barbara, Badger, Murray R., Dean Price, G.
Julkaistu 1998

Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR...

Tekijä Osarogiagbon, Raymond U., Cappuzzo, Federico, Ciuleanu, Tudor, Leon, Larry, Klughammer, Barbara
Julkaisussa Transl Lung Cancer Res (2015)

Pooled analysis of clinical outcome for EGFR TKI-treated patients with EGFR mutation-positive NSCLC

Tekijä Paz-Ares, Luis, Soulières, Denis, Moecks, Joachim, Bara, Ilze, Mok, Tony, Klughammer, Barbara
Julkaistu 2014

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

Tekijä Paz-Ares, Luis, Soulières, Denis, Melezínek, Ivan, Moecks, Joachim, Keil, Lorenz, Mok, Tony, Rosell, Rafael, Klughammer, Barbara
Julkaistu 2010

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Tekijä van den Bent, Martin J., Brandes, Alba A., Rampling, Roy, Kouwenhoven, Mathilde C.M., Kros, Johan M., Carpentier, Antoine F., Clement, Paul M., Frenay, Marc, Campone, Mario, Baurain, Jean-Francois, Armand, Jean-Paul, Taphoorn, Martin J.B., Tosoni, Alicia, Kletzl, Heidemarie, Klughammer, Barbara, Lacombe, Denis, Gorlia, Thierry
Julkaistu 2009

Clinical Validation of a PCR Assay for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer: Retrospective Testing of Specimens from the EURTAC Trial

Tekijä Benlloch, Susana, Botero, Maria Luisa, Beltran-Alamillo, Jordi, Mayo, Clara, Gimenez-Capitán, Ana, de Aguirre, Itziar, Queralt, Cristina, Ramirez, Jose Luis, Cajal, Santiago Ramón y., Klughammer, Barbara, Schlegel, Mariette, Bordogna, Walter, Chen, David, Zhang, Guili, Kovach, Barbara, Shieh, Felice, Palma, John F., Wu, Lin, Lawrence, H. Jeffrey, Taron, Miquel
Julkaistu 2014

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

Tekijä Röth, Alexander, Nishimura, Jun-ichi, Nagy, Zsolt, Gaàl-Weisinger, Julia, Panse, Jens, Yoon, Sung-Soo, Egyed, Miklos, Ichikawa, Satoshi, Ito, Yoshikazu, Kim, Jin Seok, Ninomiya, Haruhiko, Schrezenmeier, Hubert, Sica, Simona, Usuki, Kensuke, Sicre de Fontbrune, Flore, Soret, Juliette, Sostelly, Alexandre, Higginson, James, Dieckmann, Andreas, Gentile, Brittany, Anzures-Cabrera, Judith, Shinomiya, Kenji, Jordan, Gregor, Biedzka-Sarek, Marta, Klughammer, Barbara, Jahreis, Angelika, Bucher, Christoph, Peffault de Latour, Régis
Julkaisussa Blood (2020)